Despite documentation of these issues over decades, no warning was included on Suboxones label until the FDA mandated it in 2022
The question has shifted from "is it too expensive to cover GLP-1?" to "is it too expensive not to?" As clinical data accumulates showing that GLP-1 medications reduce the incidence and severity of the most expensive chronic diseases, payers are recognizing that proactive treatment of obesity saves money compared to treating its downstream consequences
These devices can also cause physical damage in the gut, either by blocking the digestive tract or from sharp parts inside
Further studies will be needed to investigate the physiological relevance of inhibiting or activating NAPRT in non-cancer chronic conditions, such as aging and age-associated diseases
Semaglutide has risen in popularity as the top weight loss drug for those who have struggled with obesity and other preexisting conditions such as diabetes and insulin resistance
If you cannot keep fluids down or are having multiple loose stools daily, the resulting hemoconcentration could create clotting conditions
